메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

'김갑성' 기자의 전체기사

Asia Pacific liver health leaders and Ministry of Health officials…

TAIPEI, Nov. 6, 2025 -- Senior health officials, clinicians, and policy leaders from across the Asia Pacific region convened in Taipei for the hepatocellular carcinoma (HCC) Leadership & Policy Forum, hosted by the APAC Liver Disease Alliance, the Taiwan Health Promotion Administration and the Taiwan National Health Insurance Administration. The event marked a pivotal moment in regional efforts to combat HCC, the most common type of liver cancer and a major public health challenge across the Asia-Pacific. During the Forum, the Alliance launched a peer-reviewed publication t
- 김갑성 기자
- 2025-11-06 19:49
Uniting Global Minds to Shape the Future of Healthcare -- The…

HONG KONG, Nov. 6, 2025 -- In the era of artificial intelligence, the rapid advancements in AI and robotics are revolutionizing healthcare — reshaping diagnosis, treatment, and health management. How to deeply integrate these cutting-edge technologies into clinical practice, and transform innovative algorithms into tangible tools to save lives, has become a global priority. On 26 October, the 3rd Hong Kong Clinical-driven Robotics and Embodied AI Technology (CREATE) Symposium opened at the Hong Kong Convention and Exhibition Centre. Organized by the Centre for AI and Robotics (CAIR), H
- 김갑성 기자
- 2025-11-06 18:06
Millennium Technology Prize opens its nomination period f…

HELSINKI, Nov. 6, 2025 -- The world's leading innovation award, Millennium Technology Prize, will be awarded again in May 2027. The eligibility criteria of the prize have been expanded to even more future-oriented innovations that improve the well-being of humankind and the planet and stimulate further research and development. The global call for nominations will be open for groundbreaking innovations between 6 November 2025 and 27 February 2026. The Millennium Technology Prize is the pre-eminent one-million-euro award focused on technological innovations for a better life. The winnin
- 김갑성 기자
- 2025-11-06 16:15
Leading Fertility Specialist Associate Professor Gavin Sacks…

SYDNEY, Nov. 6, 2025 -- Genea Fertility, Australia's pioneering fertility network, is pleased to announce the appointment of internationally renowned fertility specialist, Associate Professor Gavin Sacks, to its medical leadership team, continuing the organisation's 40-year tradition of clinical leadership excellence. Dr Sacks brings over 20 years of experience at the forefront of reproductive medicine and is recognised globally for his groundbreaking research in reproductive medicine including luteinising hormone (LH) supplementation, innovative stimulation protocols, genomic screenin
- 김갑성 기자
- 2025-11-06 16:09
KT&G sees record quarterly revenue and operating profit in…

Quarterly global cigarette revenue surpasses KRW 500 billion for the first time; cigarette& NGP performs solidly hand-in-hand Acquires ASF jointly with Altria, modern product's global expansion to gain momentum SEOUL, South Korea, Nov. 6, 2025 -- KT&G (KRX: 033780) presented its simultaneous achievement of record-high quarterly revenue and operating profit based on core business competitiveness and profitability-focused growth strategy, announcing its according upward adjustment of yearly guidance during an earnings call held on the 6th. KT&a
- 김갑성 기자
- 2025-11-06 15:49
International Symposium on Myofunctional Therapy Conclu…

SHANGHAI, Nov. 5, 2025 -- The International Symposium on Myofunctional Therapy in Multidisciplinary Collaboration, hosted by the Chinese Association of Orofacial Myology (CHAOM) and supported by Smartee Denti-Technology, concluded successfully in Shanghai. The event brought together leading clinicians, educators, and researchers from China and the United States to examine the evolving role of orofacial myofunctional therapy (OMT) in contemporary orthodontic practice. OMT Gains Ground as a Critical Component of Orthodontic Diagnostics and Treatment Planning Keynote speake
- 김갑성 기자
- 2025-11-06 15:35
Lunai Bioworks achieves complete regression of both prim…

Lunai Bioworks Announces Publication of Second-Generation Allogeneic Dendritic Cell Therapy Platform in the journal "Vaccines". LOS ANGELES, Nov. 6, 2025 -- Lunai Bioworks (NASDAQ: LNAI), an AI-powered drug discovery and biodefense company, has announced a major scientific breakthrough: its next-generation immune cell therapy led to complete regression of both primary and metastatic pancreatic tumors in humanized mouse models. The study was published in a new Brief Report in Vaccines on November 2, 2025. The peer-reviewed Brief Report details the develo
- 김갑성 기자
- 2025-11-06 14:11
THE ADECCO GROUP Q3 2025 RESULTS

AD HOC ANNOUNCEMENT pursuant to Art. 53 Listing Rules of SIX Swiss Exchange Strong share gains, good growth and improved profit margin ZURICH, Nov. 6, 2025 -- HIGHLIGHTS Further strong market share gains, Group +375 bps and Adecco +300 bps Group revenues +3.4% yoy, and +3.0% qoq, with all GBUs improving sequentially Adecco GBU revenues +4.5% yoy; Europe returned to growth; Americas +20% yoy, APAC +9% yoy Akkodis GBU revenues -3% yoy; German turnaround progressing well LHH GBU revenues +4% yoy, led by CT +9% yoy, Ezra +59% yoy Healthy 1
- 김갑성 기자
- 2025-11-06 13:45
Alphamab Oncology Showcases Cutting-edge Breakthroug…

SUZHOU, China, Nov. 6, 2025 -- The 16th World ADC San Diego, held from November 3–6, 2025, brought together industry leaders in San Diego, USA. Dr. Ting Xu, Founder, Chairman, and CEO of Alphamab Oncology, was invited to deliver a presentation titled "JSKN021: EGFR/HER3 Targeted Dual-payload ADC", showcasing the company's cutting-edge technological breakthroughs and innovative achievements in the ADC field to a global audience. The modularly designed dual-payload ADC platform technology and the prominent preclinical efficacy of JSKN021 garnered attention from attendees, making it on
- 김갑성 기자
- 2025-11-06 12:05
The 2025 Chinese Congress on Holistic Integrative Oncolog…

KUNMING, China, Nov. 6, 2025 -- From November 6 to 9, 2025, the highly anticipated 2025 CCHIO will be grandly held in Kunming, the "Spring City". Hosted by the Chinese Anti-Cancer Association and the Secretariat of the Tengchong Scientists Forum Organizing Committee, co-hosted by the World Association of Integrative Oncology (WAIO) and the China Institute of Integrative Medicine Development Strategy, and jointly organized by Yunnan Cancer Hospital, Kunming Medical University and Yunnan Anti-Cancer Association, this congress aims to become a significant milestone for academic exchang
- 김갑성 기자
- 2025-11-06 10:58

이전

31 32 33 34 35 36 37 38 39 40

많이 본 기사

최근기사

2025-12-10_WED

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 12월 10일 21시 20분